Vyome Therapeutics is working to treat inflammatory diseases using locally-acting, novel and next generation therapeutic solutions with validated mechanisms of action and effective formulations for site-targeted applications. With this approach to drug development, Vyome is working to develop safer and more effective alternatives to standards of care in multifactorial diseases of high unmet need which are underpinned by inflammation.

    Latest at Vyome Therapeutics

    Latest at Vyome Therapeutics

    Vyome Therapeutics Strengthens Executive Management with Appointment of Craig Tooman as Chief Operating Officer and Chief Financial Officer

    View More
    About Vyome Therapeutics

    About Vyome Therapeutics

    Read More to know about Vyome's Vision and Plans

    View More
    R&D Programs

    R&D Programs

    Read More to know about Vyome's innovative and patented technology platforms for partnering opportunities

    View More
    Pipeline

    Pipeline

    Read More to know about Vyome's pipeline of novel products developed using breakthrough technology platforms, and available for partnering

    View More
    Vyome's Leadership Team

    Vyome's Leadership Team

    Team with expertise, demonstrated capability and track record of launching 50+ drugs

    View More
    Partnering

    Partnering

    Read More to discover Partnering opportunities with Vyome on technology platforms and products

    View More

    Copyright © 2015 Vyome Therapeutics Inc. All rights reserved.